Natixis Advisors’s Lexicon Pharmaceuticals LXRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-86,094
| Closed | -$207K | – | 1610 |
|
|
2024
Q1 | $207K | Buy |
+86,094
| New | +$207K | ﹤0.01% | 1518 |
|
|
2023
Q3 | – | Sell |
-87,425
| Closed | -$200K | – | 1514 |
|
|
2023
Q2 | $200K | Sell |
87,425
-80
| -0.1% | -$183 | ﹤0.01% | 1468 |
|
|
2023
Q1 | $213K | Buy |
+87,505
| New | +$213K | ﹤0.01% | 1455 |
|
|
2022
Q4 | – | Sell |
-88,411
| Closed | -$212K | – | 1486 |
|
|
2022
Q3 | $212K | Buy |
+88,411
| New | +$212K | ﹤0.01% | 1432 |
|
|
2022
Q1 | – | Sell |
-93,969
| Closed | -$370K | – | 1450 |
|
|
2021
Q4 | $370K | Sell |
93,969
-568
| -0.6% | -$2.24K | ﹤0.01% | 1291 |
|
|
2021
Q3 | $455K | Sell |
94,537
-208
| -0.2% | -$1K | ﹤0.01% | 1223 |
|
|
2021
Q2 | $435K | Sell |
94,745
-114
| -0.1% | -$523 | ﹤0.01% | 1227 |
|
|
2021
Q1 | $556K | Sell |
94,859
-6,134
| -6% | -$36K | ﹤0.01% | 1153 |
|
|
2020
Q4 | $345K | Buy |
+100,993
| New | +$345K | ﹤0.01% | 1165 |
|